Hims Hers Really Growth Stock Faces Reality Check Now
Hims & Hers Health shifts to selling branded Wegovy and Ozempic after a settlement with Novo Nordisk, reversing regul...
Identify the mix that offers broader exposure for retirement by comparing Sp500 and total market allocations and adjusting for risk.
28,595 articlesHims & Hers Health shifts to selling branded Wegovy and Ozempic after a settlement with Novo Nordisk, reversing regul...
Capital One’s stock sits near $184 after a wave of acquisitions and an earnings miss. Here’s what Wall Street expects...
Among the market’s biggest names, only a few of the so-called magnficent seven look like buys today. This piece digs ...
In a briefing, the legal chief puts clarity on the bill's fate, pointing to sub-50% odds this Senate session due to s...
AI-driven changes across industries are upending job security and prompting a reevaluation of savings. Analysts advoc...
A Senate committee greenlit the CLARITY Act in a 15-9 vote, sending the bill to the full chamber. Markets jumped as X...
Trump Media’s underwater bitcoin moved to Crypto.com, fueling questions about how much of the reserve is freely held ...
Allium, a crypto analytics startup, secures a $40 million Series B to scale its data platform for institutional clien...
When the Doctor Who 2026 Christmas special was canceled, fans faced more than a calendar change. This article transla...
A landmark court ruling opens a path for refunds on tariffs. Americans demanding refunds from tariffs are turning to ...
XRP surged about 9% on the session, lifting from roughly $1.10 to $1.24 as ETF inflows and a rising technical pattern...
Gate Technology has secured a Malta PSD2 Payment Institution license, strengthening EU payment rails for stablecoins ...